Companies in #Cardiovascular, Renal and Metabolism (Farxiga, Brilinta)
Found 1 company operating in this sector.
AstraZeneca is a global biopharmaceutical company developing and commercializing medicines across oncology, cardiovascular, renal, metabolism, and respiratory diseases. The company has a deep and diversified late-stage pipeline including Tagrisso, Imfinzi, Enhertu, Calquence, and Farxiga, with multiple Phase 3 readouts and launches scheduled for 2026 across multiple therapeutic areas.